Cannabidiol tempers alcohol intake and neuroendocrine and behavioural correlates in alcohol binge drinking adolescent rats. Focus on calcitonin gene‐related peptide's brain levels

Abstract

AbstractAlcohol binge drinking is common among adolescents and may challenge the signalling systems that process affective stimuli, including calcitonin gene‐related peptide (CGRP) signalling. Here, we employed a rat model of adolescent binge drinking to evaluate reward‐, social‐ and aversion‐related behaviour, glucocorticoid output and CGRP levels in affect‐related brain regions. As a potential rescue, the effect of the phytocannabinoid cannabidiol was explored. Adolescent male rats underwent the intermittent 20% alcohol two‐bottle choice paradigm; at the binge day (BD) and the 24 h withdrawal day (WD), we assessed CGRP expression in medial prefrontal cortex (mPFC), nucleus accumbens (NAc), amygdala, hypothalamus and brainstem; in addition, we evaluated sucrose preference, social motivation and drive, nociceptive response, and serum corticosterone levels. Cannabidiol (40 mg/kg, i.p.) was administered before each drinking session, and its effect was measured on the above‐mentioned readouts. At BD and WD, rats displayed decreased CGRP expression in mPFC, NAc and amygdala; increased CGRP levels in the brainstem; increased response to rewarding‐ and nociceptive stimuli and decreased social drive; reduced serum corticosterone levels. Cannabidiol reduced alcohol consumption and preference; normalised the abnormal corticolimbic CGRP expression, and the reward and aversion‐related hyper‐responsivity, as well as glucocorticoid levels in alcohol binge‐like drinking rats. Overall, CGRP can represent both a mediator and a target of alcohol binge‐like drinking and provides a further piece in the intricate puzzle of alcohol‐induced behavioural and neuroendocrine sequelae. CBD shows promising effects in limiting adolescent alcohol binge drinking and rebalancing the bio‐behavioural abnormalities.